219 related articles for article (PubMed ID: 25598043)
1. Increased pre-surgical numbers of endothelial progenitor cells and circulating endothelial cells in colorectal cancer fail to predict outcome.
Ramcharan KS; Lip GY; Stonelake PS; Blann AD
Int J Colorectal Dis; 2015 Mar; 30(3):315-21. PubMed ID: 25598043
[TBL] [Abstract][Full Text] [Related]
2. Angiogenin outperforms VEGF, EPCs and CECs in predicting Dukes' and AJCC stage in colorectal cancer.
Ramcharan SK; Lip GY; Stonelake PS; Blann AD
Eur J Clin Invest; 2013 Aug; 43(8):801-8. PubMed ID: 23683169
[TBL] [Abstract][Full Text] [Related]
3. Effect of standard chemotherapy and antiangiogenic therapy on plasma markers and endothelial cells in colorectal cancer.
Ramcharan KS; Lip GY; Stonelake PS; Blann AD
Br J Cancer; 2014 Oct; 111(9):1742-9. PubMed ID: 25211664
[TBL] [Abstract][Full Text] [Related]
4. Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index.
Goon PK; Lip GY; Stonelake PS; Blann AD
Neoplasia; 2009 Aug; 11(8):771-9. PubMed ID: 19649207
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of anti-angiogenic therapy in metastatic colorectal cancer (mCRC): original data and review of the literature.
Pohl M; Werner N; Munding J; Tannapfel A; Graeven U; Nickenig G; Schmiegel W; Reinacher-Schick A
Z Gastroenterol; 2011 Oct; 49(10):1398-406. PubMed ID: 21964893
[TBL] [Abstract][Full Text] [Related]
7. Circulating and progenitor endothelial cells are abnormal in patients with different types of von Willebrand disease and correlate with markers of angiogenesis.
Gritti G; Cortelezzi A; Bucciarelli P; Rezzonico F; Lonati S; La Marca S; Silvestris I; Federici AB
Am J Hematol; 2011 Aug; 86(8):650-6. PubMed ID: 21630316
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
[TBL] [Abstract][Full Text] [Related]
9. Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study.
Ahmed FW; Rider R; Glanville M; Narayanan K; Razvi S; Weaver JU
Cardiovasc Diabetol; 2016 Aug; 15(1):116. PubMed ID: 27561827
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite instability and manifestations of angiogenesis in stage IV of sporadic colorectal carcinoma.
Otto W; Macrae F; Sierdziński J; Smaga J; Król M; Wilińska E; Zieniewicz K
Medicine (Baltimore); 2019 Jan; 98(1):e13956. PubMed ID: 30608431
[TBL] [Abstract][Full Text] [Related]
11. Circulating endothelial progenitor cells as a predictor of response to cardiac resynchronization therapy: the missing piece of the puzzle?
António N; Soares A; Carvalheiro T; Fernandes R; Paiva A; Ventura M; Cristóvão J; Elvas L; Gonçalves L; Providência LA; Ribeiro CF; Pego GM
Pacing Clin Electrophysiol; 2014 Jun; 37(6):731-9. PubMed ID: 24383551
[TBL] [Abstract][Full Text] [Related]
12. High levels of circulating VEGFR2+ Bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignancies.
Taylor M; Rössler J; Geoerger B; Laplanche A; Hartmann O; Vassal G; Farace F
Clin Cancer Res; 2009 Jul; 15(14):4561-71. PubMed ID: 19605404
[TBL] [Abstract][Full Text] [Related]
13. Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib.
Vroling L; van der Veldt AA; de Haas RR; Haanen JB; Schuurhuis GJ; Kuik DJ; van Cruijsen H; Verheul HM; van den Eertwegh AJ; Hoekman K; Boven E; van Hinsbergh VW; Broxterman HJ
Angiogenesis; 2009; 12(1):69-79. PubMed ID: 19212818
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of vascular endothelial growth factor and microvessel counting as prognostic indicators in node-negative colorectal cancer.
Boxer GM; Tsiompanou E; Levine T; Watson R; Begent RH
Tumour Biol; 2005; 26(1):1-8. PubMed ID: 15741766
[TBL] [Abstract][Full Text] [Related]
15. Increased serum levels of fractalkine and mobilisation of CD34
Benyamine A; Magalon J; Cointe S; Lacroix R; Arnaud L; Bardin N; Rossi P; Francès Y; Bernard-Guervilly F; Kaplanski G; Harlé JR; Weiller PJ; Berbis P; Braunstein D; Jouve E; Lesavre N; Couranjou F; Dignat-George F; Sabatier F; Paul P; Granel B
Arthritis Res Ther; 2017 Mar; 19(1):60. PubMed ID: 28320472
[TBL] [Abstract][Full Text] [Related]
16. Changes in serum vascular endothelial growth factor and endostatin concentrations associated with circulating endothelial progenitor cells after acute ischemic stroke.
Xue L; Chen H; Zhang T; Chen J; Geng Z; Zhao Y
Metab Brain Dis; 2017 Apr; 32(2):641-648. PubMed ID: 28093678
[TBL] [Abstract][Full Text] [Related]
17. Circulating endothelial cells in acute ischaemic stroke.
Nadar SK; Lip GY; Lee KW; Blann AD
Thromb Haemost; 2005 Oct; 94(4):707-12. PubMed ID: 16270621
[TBL] [Abstract][Full Text] [Related]
18. The evaluation of circulating endothelial progenitor cells and related angiogenic markers as prognostic factors in soft-tissue tumors.
Karampinis I; Joas E; Dreyer A; Ronellenfitsch U; Jakob J; Hohenberger P; Nowak K
Eur J Surg Oncol; 2018 Apr; 44(4):496-501. PubMed ID: 29397265
[TBL] [Abstract][Full Text] [Related]
19. Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy.
Duda DG; Cohen KS; di Tomaso E; Au P; Klein RJ; Scadden DT; Willett CG; Jain RK
J Clin Oncol; 2006 Mar; 24(9):1449-53. PubMed ID: 16549839
[TBL] [Abstract][Full Text] [Related]
20. Circulating inflammatory factors associated with worse long-term prognosis in colorectal cancer.
Olsen RS; Nijm J; Andersson RE; Dimberg J; Wågsäter D
World J Gastroenterol; 2017 Sep; 23(34):6212-6219. PubMed ID: 28974887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
